Assessing NH300094, a novel dopamine and serotonin receptor modulator with cognitive enhancement property for treating schizophrenia
Background: Schizophrenia is a serious psychiatric disorder that significantly affects the quality of life of patients. The objective of this study is to discover a novel antipsychotic candidate with highly antagonistic activity against both serotonin and dopamine receptors, demonstrating robust eff...
| 發表在: | Frontiers in Pharmacology |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Article |
| 語言: | 英语 |
| 出版: |
Frontiers Media S.A.
2024-01-01
|
| 主題: | |
| 在線閱讀: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1298061/full |